Abstract
Medicated jellies are widely used by a large part of patients, especially by people with swallowing difficulties. Preformulation studies play an essential role in the development of new pharmaceutical formulations. The present study aimed to formulate and evaluate medicated jellies containing perphenazine, an antipsychotic drug from the group of phenothiazine compounds used to treat schizophrenia and other mental disorders. Typical gelling agents such as sodium alginate (Alg), gelatine (Gel), and pectin (Pec) were used to develop the medicated jellies. In addition to the biopolymers, components such as benzoic acid (BenzAc), citric acid (CitAc), sodium citrate (NaCit), sorbitol (Sorb), and xylitol (Xyl) were also used. Before preparing the jellies, the moist binary mixture between each component of the jelly and the active substance was analyzed to investigate the compatibility of the substances. The active substance, moist binary mixture, and medicated jellies were analyzed by FTIR_UATR spectroscopy, UV-Vis spectroscopy, and thermogravimetry (TGA).
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
